Eiger BioPharmaceuticals names new director
19 July 2022 -

Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a US-based commercial-stage biopharmaceutical company, announced on Monday that it has named Lisa Kelly-Croswell as its new director.

Kelly-Croswell has around 25 years of experience in the biopharmaceutical and life sciences industries. Presently, she is the senior vice president and chief human resources officer at Boston Medical Center Health System. She has headed Human Resources for Vertex Pharmaceuticals and has also held roles within Nitromed, Cigna, and Monsanto. Presently, she serves on the board of Synlogic and is a current and past board member of multiple non-profit organisations.

Kelly-Croswell said, 'I am delighted to join the Eiger board at this exciting time in its evolution to a commercial stage biopharmaceutical company. The company's progress to date has been impressive and the diverse pipeline with breakthrough therapy programs is most promising for patients that may ultimately benefit. I look forward to being part of Eiger's future growth and continued success.'